232 related articles for article (PubMed ID: 8814370)
1. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients.
Teo PM; Kwan WH; Yu P; Lee WY; Leung SF; Choi P
Clin Oncol (R Coll Radiol); 1996; 8(3):160-6. PubMed ID: 8814370
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
[TBL] [Abstract][Full Text] [Related]
3. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
[TBL] [Abstract][Full Text] [Related]
4. [Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].
Lin SJ; Pan JJ; Wu JX; Han L; Pan CZ
Ai Zheng; 2007 Feb; 26(2):208-11. PubMed ID: 17298755
[TBL] [Abstract][Full Text] [Related]
5. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
[TBL] [Abstract][Full Text] [Related]
6. Improved local control for early T-stage nasopharyngeal carcinoma--a tale of two hospitals.
Teo PM; Leung SF; Fowler J; Leung TW; Tung Y; O SK; Lee WY; Zee B
Radiother Oncol; 2000 Nov; 57(2):155-66. PubMed ID: 11054519
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
8. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
[TBL] [Abstract][Full Text] [Related]
9. Early stage nasopharyngeal carcinoma: radiotherapy dose and time factors in tumor control.
Chang JT; See LC; Liao CT; Chen LH; Leung WM; Chen SW; Chen WC
Jpn J Clin Oncol; 1998 Mar; 28(3):207-13. PubMed ID: 9614445
[TBL] [Abstract][Full Text] [Related]
10. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
[TBL] [Abstract][Full Text] [Related]
11. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose.
Teo PM; Leung SF; Lee WY; Zee B
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):445-58. PubMed ID: 10661353
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma.
Teo P; Lee WY; Yu P
Radiother Oncol; 1996 Jun; 39(3):209-21. PubMed ID: 8783397
[TBL] [Abstract][Full Text] [Related]
13. Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma: a study based on CT scanning.
Yu KH; Teo PM; Lee WY; Leung SF; Choi PH; Johnson PJ
Clin Oncol (R Coll Radiol); 1994; 6(3):167-71. PubMed ID: 8086351
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Chen YQ; Deng XG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):165-70. PubMed ID: 15337552
[TBL] [Abstract][Full Text] [Related]
15. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
Hwang JM; Fu KK; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
[TBL] [Abstract][Full Text] [Related]
16. The role of brachytherapy in early-stage nasopharyngeal carcinoma.
Chang JT; See LC; Tang SG; Lee SP; Wang CC; Hong JH
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1019-24. PubMed ID: 8985022
[TBL] [Abstract][Full Text] [Related]
17. Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost.
Wang CC
Am J Clin Oncol; 1991 Feb; 14(1):5-8. PubMed ID: 1987739
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma{private}.
Leung TW; Wong VY; Sze WK; Lui CM; Tung SY
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):361-7. PubMed ID: 17892917
[TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]